A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Journal
Clinical Cancer Research
Journal Volume
28
Journal Issue
1
Pages
106-115
Date Issued
2022
Author(s)
Kuemmel S.
Campone M.
Loirat D.
Lopez R.L.
Thaddeus Beck J.
de Laurentiis M.
Im S.-A.
Kim S.-B.
Kwong A.
Steger G.G.
Adelantado E.Z.
Duhoux F.P.
Greil R.
Kuter I.
Tibau A.
?zg?ro?lu M.
Scholz C.W.
Singer C.F.
Vega E.
Wimberger P.
Zamagni C.
Couillebault X.-M.
Fan L.
Guerreiro N.
Mataraza J.
Sand-Dejmek J.
Chan A.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article